Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/20/22 → … |
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
- Satkunasivam, Raj (PI)
- Butler, E. Brian (Key Personnel)
- Chen, Shu-Hsia (Key Personnel)
- Esnaola, Nestor F. (Key Personnel)
- Farach, Andrew M. (Key Personnel)
- Teh, Bin S. (Key Personnel)
- Zhang, Jun (Key Personnel)
Project: Clinical Trial